2C-B-FLY

2C-B-FLY is a psychedelic drug of the 2C family. It was first synthesized by Aaron P. Monte in 1996. It is notable for having a full 35 mg dose fit within the default size of a "research pellet", which is typically only 10 mg for most research chemicals.

History

2C-B-FLY was first synthesized by Aaron P. Monte in 1996. The synthesis was published in 1998. A detailed review of the drug was published in 2005.

Pharmacology

2C-B-FLY is a serotonin receptor agonist. It is thought to act primarily on the 5-HT2A receptor, but also has effects on the 5-HT1A receptor and the 5-HT2C receptor. The drug has a high affinity for the 5-HT2B receptor, which is thought to be responsible for its cardiotoxicity.

Effects

The effects of 2C-B-FLY are similar to those of other psychedelic drugs. These include hallucinations, euphoria, and altered perception. The drug also has empathogenic effects, similar to MDMA. The effects typically last for 6-8 hours, but can last up to 12 hours in some cases.

Legal status

2C-B-FLY is illegal in many countries, including the United States, United Kingdom, and Australia. It is also illegal in many European countries, including Germany, France, and Sweden.

See also

• 2C-B
• 2C-I
• 2C-E
• 2C-T-7
• 2C-T-2

References

2C-B-FLY Resources
Latest articles Most recent articles Ongoing trials	Wikipedia